Cardiac Imaging in Systemic Disorders: the ORACLES Registry
ConditionLupus
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris
About this trial
Autoimmune diseases affect a total of 5 to 10% of the population. These diseases are associated with an increased risk of developing cardiovascular pathologies. Modern cardiac imaging tools could provide a better understanding of these complications, enabling earlier diagnosis and detection of patients most at risk. Yet, the diagnostic and prognostic value of multimodal cardiac imaging in these diseases is under-researched. The current registry aimed at investigating the diagnostic and prognostic value of cardiac imaging in autoimmune and systemic disorders.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Suspected or diagnosed autoimmune, inflammatory and/or systemic disease.
Cross-sectional cardiac imaging including either nonenhanced cardiac computed tomography, enhanced coronary angiogram-computed tomography, or cardiac magnetic resonance imaging
Disqualifiers
Age < 18 years
Objection to study participation
Patient under legal protection
Trial population
Suspected or diagnosed autoimmune, inflammatory and/or systemic disease.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
data collection
Other interventiondata collection
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
MACE (major adverse cardiovascular events)
Composite outcome of myocardial infarction, stroke or cardiovascular death.
Time frame
Through study completion, an average of 10 yearSecondary outcomes
1
ASCVD (atherosclerotic cardiovascular disease)
Composite outcome of acute coronary syndrome, stroke and peripheral artery disease.
Time frame
Through study completion, an average of 10 year2
Cardiovascular events (all)
MACE, ASCVD, device implantation, coronary artery disease, heart failure, rhythm and conduction disorders, valvular disorders, cardiovascular interventions, fatal and non fatal.
Time frame
Through study completion, an average of 10 yearLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: